ClearPoint Neuro, Inc. (CLPT) — Financial statements
Income statement, balance sheet, and cash flow for ClearPoint Neuro, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 37↑17.8% | 31↑31.0% | 24↑16.6% | 21↑26.1% | 16 | |
| Cost of Revenue | 14↑16.4% | 12↑18.6% | 10↑47.3% | 7↑35.6% | 5 | |
| Gross Profit | 23↑18.7% | 19↑40.5% | 14↑0.6% | 14↑21.6% | 11 | |
| Operating Expenses | ||||||
| R&D Expenses | 14↑12.1% | 12↑5.8% | 12↑7.5% | 11↑17.4% | 9 | |
| General & Administrative Expenses | 16↑37.5% | 12↑2.1% | 12↑22.3% | 10↑20.2% | 8 | |
| Selling & Marketing Expenses | 16↑13.7% | 14↑15.0% | 13↑34.6% | 9↑29.7% | 7 | |
| SG&A Expenses | 33↑24.5% | 26↑8.7% | 24↑28.4% | 19↑24.7% | 15 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 47↑20.6% | 39↑7.8% | 36↑20.8% | 30↑21.9% | 24 | |
| Total Costs & Expenses | 61↑19.6% | 51↑10.2% | 46↑25.8% | 37↑24.3% | 30 | |
| Operating Results | ||||||
| Operating Income | -24↓22.4% | -20↑12.0% | -22↓37.4% | -16↓22.1% | -13 | |
| Depreciation & Amortization | 2↑17.6% | 2↑30.6% | 1↑87.5% | 0.78↑12.3% | 0.69 | |
| EBITDA | -22↓22.9% | -18↑15.0% | -21↓34.7% | -16↓22.2% | -13 | |
| EBIT | -24↓22.4% | -20↑12.0% | -22↓37.3% | -16↓21.7% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1↓234.7% | 0.87↑125.9% | 0.39↑576.5% | -0.08↑91.7% | -0.97 | |
| Interest Income | 1↑39.1% | 0.87↑125.9% | 0.39 | 0.00 | 0.00 | |
| Interest Expense | 2 | 0.00 | 0.00↓100.0% | 0.08↓91.7% | 0.97 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 0.02↓65.1% | 0.06 | |
| Other Income / Expenses | -1↓258.8% | 0.83↑133.1% | 0.36↑446.6% | -0.10↑90.1% | -1 | |
| Income Before Tax | -25↓34.7% | -19↑14.4% | -22↓34.4% | -16↓14.1% | -14 | |
| Income Tax Expense | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -26↓35.0% | -19↑14.4% | -22↓34.4% | -16↓14.1% | -14 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -26↓35.0% | -19↑14.4% | -22↓34.4% | -16↓14.1% | -14 | |
| Bottom-Line Net Income | -26↓35.0% | -19↑14.4% | -22↓34.4% | -16↓14.1% | -14 | |
| EPS (Basic) | -0.90↓28.6% | -0.70↑22.2% | -0.90↓32.4% | -0.68↑1.4% | -0.69 | |
| EPS (Diluted) | -0.90↓28.6% | -0.70↑22.2% | -0.90↓32.4% | -0.68↑1.4% | -0.69 | |
| Weighted Average Shares | 28↑4.8% | 27↑9.8% | 25↑1.8% | 24↑16.6% | 21 | |
| Weighted Average Diluted Shares | 28↑4.8% | 27↑9.8% | 25↑1.8% | 24↑16.6% | 21 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.